194 related articles for article (PubMed ID: 30755669)
1. PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma.
Ma H; Hockla A; Mehner C; Coban M; Papo N; Radisky DC; Radisky ES
Sci Rep; 2019 Feb; 9(1):1844. PubMed ID: 30755669
[TBL] [Abstract][Full Text] [Related]
2. PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer.
Hockla A; Miller E; Salameh MA; Copland JA; Radisky DC; Radisky ES
Mol Cancer Res; 2012 Dec; 10(12):1555-66. PubMed ID: 23258495
[TBL] [Abstract][Full Text] [Related]
3. Keratinocyte-specific mesotrypsin contributes to the desquamation process via kallikrein activation and LEKTI degradation.
Miyai M; Matsumoto Y; Yamanishi H; Yamamoto-Tanaka M; Tsuboi R; Hibino T
J Invest Dermatol; 2014 Jun; 134(6):1665-1674. PubMed ID: 24390132
[TBL] [Abstract][Full Text] [Related]
4. Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109.
Hockla A; Radisky DC; Radisky ES
Breast Cancer Res Treat; 2010 Nov; 124(1):27-38. PubMed ID: 20035377
[TBL] [Abstract][Full Text] [Related]
5. Shear Stress Drives the Cleavage Activation of Protease-Activated Receptor 2 by PRSS3/Mesotrypsin to Promote Invasion and Metastasis of Circulating Lung Cancer Cells.
Zhou M; Li K; Luo KQ
Adv Sci (Weinh); 2023 Sep; 10(25):e2301059. PubMed ID: 37395651
[TBL] [Abstract][Full Text] [Related]
6. The P(2)' residue is a key determinant of mesotrypsin specificity: engineering a high-affinity inhibitor with anticancer activity.
Salameh MA; Soares AS; Hockla A; Radisky DC; Radisky ES
Biochem J; 2011 Nov; 440(1):95-105. PubMed ID: 21806544
[TBL] [Abstract][Full Text] [Related]
7. High-level expression of PRSS3 correlates with metastasis and poor prognosis in patients with gastric cancer.
Wang F; Hu YL; Feng Y; Guo YB; Liu YF; Mao QS; Xue WJ
J Surg Oncol; 2019 Jun; 119(8):1108-1121. PubMed ID: 30908656
[TBL] [Abstract][Full Text] [Related]
8. Exonic mutations associated with atopic dermatitis disrupt lympho-epithelial Kazal-type related inhibitor action and enhance its degradation.
Ramesh K; Matta SA; Chew FT; Mok YK
Allergy; 2020 Feb; 75(2):403-411. PubMed ID: 31407378
[TBL] [Abstract][Full Text] [Related]
9. KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
Ji Z; Pan X; Shang Y; Ni DT; Wu FL
Tissue Cell; 2019 Dec; 61():44-50. PubMed ID: 31759406
[TBL] [Abstract][Full Text] [Related]
10. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
11. [High expression of VEGFR3 is positively associated with poor prognosis in lung adenocarcinoma].
Li J; Zhang W; Xia H; Liu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1023-1029. PubMed ID: 31878999
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of kallikrein 5 as a novel prognostic biomarker in gastric adenocarcinoma.
Abuduhadeer X; Xu X; Aihesan K; Yilihamu M; Zhao Y; Zhang W
J Clin Lab Anal; 2021 Oct; 35(10):e23958. PubMed ID: 34510543
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of FOXP1 promotes the development of lung adenocarcinoma.
Sheng H; Li X; Xu Y
Cancer Biol Ther; 2019; 20(4):537-545. PubMed ID: 30409062
[TBL] [Abstract][Full Text] [Related]
14. PRSS3/mesotrypsin as a putative regulator of the biophysical characteristics of epidermal keratinocytes in superficial layers.
Kida M; Abe J; Hori H; Hirai Y
Sci Rep; 2024 May; 14(1):12383. PubMed ID: 38811772
[TBL] [Abstract][Full Text] [Related]
15. High Expression of PRSS3 Indicates Unfavorable Clinical Outcomes in Colon Adenocarcinoma.
Zhang Q; Wang J; Huang D; Liu G
Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):564-569. PubMed ID: 33758142
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MEG3 plays a promoting role in the proliferation, invasion, and angiogenesis of lung adenocarcinoma cells through the AKT pathway.
Li H; Wang J; Lv S; Zhang Y; Zhang C; Lige B; Dan S; Sun Y
J Cell Biochem; 2019 Sep; 120(9):16143-16152. PubMed ID: 31211438
[TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibitors of mesotrypsin from a structure-based docking screen.
Kayode O; Huang Z; Soares AS; Caulfield TR; Dong Z; Bode AM; Radisky ES
PLoS One; 2017; 12(5):e0176694. PubMed ID: 28463992
[TBL] [Abstract][Full Text] [Related]
18. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA ADAM9 facilitates the malignant behaviours of pancreatic cancer by sponging miR-217 and upregulating PRSS3 expression.
Xing C; Ye H; Wang W; Sun M; Zhang J; Zhao Z; Jiang G
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3920-3928. PubMed ID: 31810373
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic activation of human kallikrein 13 enhances malignancy of lung adenocarcinoma by promoting N-cadherin expression and laminin degradation.
Chou RH; Lin SC; Wen HC; Wu CW; Chang WS
Biochem Biophys Res Commun; 2011 Jun; 409(3):442-7. PubMed ID: 21596022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
